HOWL · Werewolf Therapeutics, Inc. · Debt
$0.93
+0.00 (+0.20%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Jul 31, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We believe there is substantial doubt about our ability to continue as a going concern for at least twelve months from the date that these condensed consolidated financial statements are issued in this Quarterly Report. We are currently evaluating strategies to raise additional capital, however, there can be no assurances that we will be successful in mitigating the conditions which raise substantial doubt about our ability to continue as a going concern in the near term, if at all.”View the 10-Q filed Jul 31, 2026
Market Cap
$46.65M
Shares
48.60M
Volume · Oct 5
239.08K
Avg daily vol (3M)
6.73M
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-06-30 | USD 0 | 10-Q filed 2026-07-31 |
| Current portion of notes payable | 2026-06-30 | USD 0 | 10-Q filed 2026-07-31 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 0 | 10-Q filed 2026-07-31 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.